Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection
Loukia Psaridi, Helena C. Maltezou, Sofia Simonidou, Ioanna Lialliou, Despina Athanasopoulou, Zoi Haila, Areti Kyrimi, Ioanna Giannopoulou, Styliani Giannousa, Maria Pseimada, Olympia Christofilea, George Dounias, Sophocles Lanitis, Eirini Kremasmenou
Topics & Concepts
MedicineBooster doseBooster (rocketry)TiterNeutralizing antibodyAntibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibody titerAntibody responseCoronavirus disease 2019 (COVID-19)ImmunityVaccinationVirologyImmunologyInternal medicineImmune systemInfectious disease (medical specialty)DiseaseAstronomyPhysicsSARS-CoV-2 and COVID-19 ResearchInfection Control and VentilationVaccine Coverage and Hesitancy